Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 1375

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 10
Chunk 1375
---
 Chair of the Audit Committee received $15,000 annually for his services. Each member of the Company’s Compensation Committee and Nominating and Corporate Governance Committee received annual remuneration of $4,500 for each committee on which they serve, and the Chairs of each of the Compensation Committee and Nominating and Corporate Governance Committee received $9,000 annually for their services.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

Equity Compensation Plan Information

The following table provides certain information as of September 30, 2025 about our common shares that may be issued under our equity compensation plans, which consists of our 2019 Equity Incentive Compensation Plan in effect at September 30, 2025:

			Plan Category

			Number of securities to be issued upon exercise of outstanding options and rights

			Weighted-average exercise price of outstanding options and rights

			Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

			(a)

			(b)

			(c)

			Equity compensation plans approved by security holders

			1,621,692
			(1)
			 
			$
			24.70
			(2)

			693,515

			Equity compensation plans not approved by security holders

			N/A

			N/A

			N/A

			Total

			1,621,692

			$
			24.70

			693,515

			(1)
			
			Includes 378,039 common shares issuable upon the exercise of outstanding options and 1,243,653 common shares issuable upon the conversion of outstanding RSUs.

			(2)

			The weighted-average exercise price does not consider shares issuable upon the conversion of outstanding RSUs, which have no exercise price.

Warrants and other equity held by directors, officers and employees outside of the compensation plans are not included in the table above.

62

Security Ownership of Certain Beneficial Owners and Management

The following tables sets forth certain information as of December 12, 2025, with respect to the beneficial ownership of our common shares by: (1) all of our directors; (2) our named executive officers listed in the Summary Compensation Table; (3) all of directors and executive officers as a group; and (4) each person known by us to beneficially